Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 7-8, 2011, Pages 565-567

  Kilicci, Cetin ^a   Bayram, Banu ^b   Ozkurt, Mete ^c   Onlu, Harun ^b   Erkasap, Nilufer ^c   Mutlu, Fezan ^c  

^a Private Mus Sifa Hospital   (Turkey)

^b MU ALPARSLAN UNIVERSITY   (Turkey)

^c ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGAR GEL ELECTROPHORESIS; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION;

ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; TURKEY; YOUNG ADULT;

EID: 79960452842     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0251     Document Type: Article

References (18)

1. Bagos PG (2009) Plasminogen activator inhibitor-I 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome. Mol Hum Reprod 15:19-26.
2. Choi SW, Gu BH, Ramakrishna S, et al. (2009) Association between a single nucleotide polymorphism in MTHFR gene and polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 145:85-88.
3. Cosan D, Kurt E, Kurt H, et al. (2009) Plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism in Turkish adult patients with asthma. Genet Test Mol Biomarkers 13: 543-546.
4. Gunes HV, Cosan DT, Ata N, et al. (2010) Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism is associated with hypertensive patients in Turkish population. Genet Test Mol Biomarkers 14:303-305.
5. Jeng JR (2003) Association of PAI-1 gene promoter 4G/5G polymorphism with plasma PAI-1 activity in Chinese patients with and without hypertension. Am J Hypertens 16:290-296.
6. Kandarakis ED, Palioniko G, Alexandraki K, et al. (2004) The prevalence of 4G5G polymorphism of plasminogen activator inhibitor (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. Eur J Endocrinol 150:793-798. (Pubitemid 38961652)
7. Karadeniz M, Erdogan M, Berdeli A, et al. (2007) 4G/5G polymorphism of PAI-1 gene and in Turkish patients with poly-cystic ovary syndrome. J Assist Reprod Genet 24:412-418. (Pubitemid 47497960)
8. Margaglione M, Cappucci G, Colaizzo D, et al. (1998) The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary disease. Arterioscler Thromb Vasc Biol 18:152-156. (Pubitemid 28277590)
9. Orio F, Palomba S, Di Biase S, et al. (2003) Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate re-ductase in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:673-679 (Pubitemid 36207807)
10. Özenli Y, Haydardedeoglu B, Miçozkadioglu I, et al. (2008) Anxiety, depression and ways of coping skills by women with polycystic ovary sendrome. A controlled study. J Turk Ger Gynecol Assoc 9:190-194.
11. Palep-Singh M, Picton HM, Yates ZR, et al. (2007) Polycystic ovary syndrome and the single nucleotide polymorphisms of methylenetetrahydrofolate reductase: a pilot observational study. Hum Fertil 10:33-41. (Pubitemid 46470348)
12. Radakovic B, Goldstajn MS (2007) MTHFR C677T mutation and 4G/5G PAI-1 polymorphism in patient with polycystic ovarian syndrome. Coll Antropol 31:919-921.
13. Roest M, Schouw YT, Banga JD, et al. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation 101:67-70.
14. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polyccstic ovary syndrome (PCOS). Hum Reprod 19:41-47.
15. Tarkun I, Cxetinarslan B, Cantürk Z, et al. (2005) The plasma homocysteine concentrations and relationship with insulin resistance in young women with polycystic ovary sydrome. Turk J Endocrinol Metab 1:23-28.
16. Tsanadis G, Vartholomatos G, Korkontzelos I, et al. (2002) Polycystic ovarian syndrome and thrombophilia. Hum Re-prod 17:314-319. (Pubitemid 34168433)
17. Unsal T, Konac E, Yesilkaya E, et al. (2009) Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome. J Assist Reprod Genet 26:205-216.
18. Wiklund P, Nilsson L, Ardnor SN, et al. (2005) Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts. Stroke 36:1661-1665. (Pubitemid 41098758)